| Entry |
Curated MiRNA |
Curated LncRNA |
Predicted MiRNA |
Predicted LncRNA |
| Record |
0 |
2 |
27 |
0 |
| Compound |
ncRNA |
Type |
Condition |
Link |
| Everolimus |
GAS5-AS1 |
Curated lncRNA |
mantle cell lymphoma |
|
| Everolimus |
GAS5-AS1 |
Curated lncRNA |
prostate cancer |
|
| Everolimus |
hsa-let-7a-5p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-let-7c |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-100-5p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-125b-5p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-127-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-136-5p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-137 |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-145-5p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-199b-5p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-218-5p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-23b-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-24-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-27b-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-299-5p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-337-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-370 |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-376a-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-376c-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-377-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-379-5p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-381-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-409-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-505-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-551b-3p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-598 |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-654-5p |
predicted miRNA |
NCI60 |
|
| Everolimus |
hsa-miR-99a-5p |
predicted miRNA |
NCI60 |
|
